⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GERN News
Geron Corp
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
globenewswire.com
GERN
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
GERN
Geron Plans to Present at Upcoming Investor Conferences
globenewswire.com
GERN
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
globenewswire.com
GERN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
globenewswire.com
GERN
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
GERN
Form 8-K
sec.gov
GERN